Proficio Capital Partners LLC Bei Gene, Ltd. Transaction History

Proficio Capital Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$120.61 - $148.29 $1,447 - $1,779	-12 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$113.99 - $146.86 $1,367 - $1,762	12 New	12 $1,000
Q1 2019 May 13, 2019	SELL	$122.82 - $151.83 $1,351 - $1,670	-11 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$107.01 - $175.15 $1,177 - $1,926	11 New	11 $2,000

253

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $22.7B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.